Anhui Huaheng Biotechnology Balance Sheet Health
Financial Health criteria checks 2/6
Anhui Huaheng Biotechnology has a total shareholder equity of CN¥1.9B and total debt of CN¥2.0B, which brings its debt-to-equity ratio to 110.1%. Its total assets and total liabilities are CN¥4.7B and CN¥2.8B respectively. Anhui Huaheng Biotechnology's EBIT is CN¥328.7M making its interest coverage ratio 11.8. It has cash and short-term investments of CN¥445.3M.
Key information
110.1%
Debt to equity ratio
CN¥2.04b
Debt
| Interest coverage ratio | 11.8x |
| Cash | CN¥445.31m |
| Equity | CN¥1.86b |
| Total liabilities | CN¥2.85b |
| Total assets | CN¥4.70b |
Recent financial health updates
Recent updates
Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Soars 35% But It's A Story Of Risk Vs Reward
Oct 21
Here's Why We Think Anhui Huaheng Biotechnology (SHSE:688639) Is Well Worth Watching
Oct 14Slammed 29% Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Screens Well Here But There Might Be A Catch
Sep 05Anhui Huaheng Biotechnology's (SHSE:688639) Profits Appear To Have Quality Issues
Sep 03Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Analysts Just Cut Their EPS Forecasts Substantially
Sep 02Many Would Be Envious Of Anhui Huaheng Biotechnology's (SHSE:688639) Excellent Returns On Capital
Aug 20Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jul 22Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Intrinsic Value Is Potentially 43% Above Its Share Price
Jul 12Is Anhui Huaheng Biotechnology (SHSE:688639) Using Too Much Debt?
Jun 21Take Care Before Jumping Onto Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Even Though It's 27% Cheaper
Jun 05We Ran A Stock Scan For Earnings Growth And Anhui Huaheng Biotechnology (SHSE:688639) Passed With Ease
May 12Earnings Report: Anhui Huaheng Biotechnology Co., Ltd. Missed Revenue Estimates By 37%
Apr 23Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Business Is Trailing The Market But Its Shares Aren't
Mar 18Financial Position Analysis
Short Term Liabilities: 688639's short term assets (CN¥1.2B) do not cover its short term liabilities (CN¥2.1B).
Long Term Liabilities: 688639's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥796.8M).
Debt to Equity History and Analysis
Debt Level: 688639's net debt to equity ratio (86.1%) is considered high.
Reducing Debt: 688639's debt to equity ratio has increased from 20.9% to 110.1% over the past 5 years.
Debt Coverage: 688639's debt is not well covered by operating cash flow (1.8%).
Interest Coverage: 688639's interest payments on its debt are well covered by EBIT (11.8x coverage).